Email: ivar.sjaastad@medisin.uio.no
Phone: +47 23016797
Education
– Veterinary medicine 1984
– MD 1991
Clinical specialities
– Cardiologi 2007
– Internal medicine 2007
Positions (selected)
– PhD student 1996-2001
– Resident 1991-1996 and 2001-2007
– Consultant 2007-present
– Professor of medicine UiO, 2010-present
– Head of department, OUS, 2017-2021
Research area
- Clinical research
- Diastolic dysfunction
- Fibrosis
- Heart failure
- Imaging
- MRI
- PET/MRI
- Ultrasound
Latest publications
view all >Sasi A, Romaine A, Erusappan PM, Melleby AO, Hasic A, Dahl CP, Broch K, Almaas VM, Puertas RD, Roderick HL, Lunde IG, Sjaastad I, Vistnes M, Christensen G (2023)
Temporal expression and spatial distribution of the proteoglycan versican during cardiac fibrosis development
Matrix Biol Plus, 19-20, 100135
PubMed 38076279 DOI 10.1016/j.mbplus.2023.100135
Temporal expression and spatial distribution of the proteoglycan versican during cardiac fibrosis development
Matrix Biol Plus, 19-20, 100135
PubMed 38076279 DOI 10.1016/j.mbplus.2023.100135
Nordén ES, Veras I, Yadav P, Løken K, Dishington H, Thorstensen C, Sjaastad I, Rasmussen H (2023)
Clinical efficacy of buprenorphine after oral dosing in rats undergoing major surgery
Lab Anim, 58 (1), 34-43
PubMed 37669442 DOI 10.1177/00236772231178417
Clinical efficacy of buprenorphine after oral dosing in rats undergoing major surgery
Lab Anim, 58 (1), 34-43
PubMed 37669442 DOI 10.1177/00236772231178417
Vistnes M, Erusappan PM, Sasi A, Nordén ES, Bergo KK, Romaine A, Lunde IG, Zhang L, Olsen MB, Øgaard J, Carlson CR, Wang CH, Riise J, Dahl CP, Fiane AE, Hauge-Iversen IM, Espe E, Melleby AO, Tønnessen T, Aronsen JM, Sjaastad I, Christensen G (2023)
Inhibition of the extracellular enzyme A disintegrin and metalloprotease with thrombospondin motif 4 prevents cardiac fibrosis and dysfunction
Cardiovasc Res, 119 (10), 1915-1927
PubMed 37216909 DOI 10.1093/cvr/cvad078
Inhibition of the extracellular enzyme A disintegrin and metalloprotease with thrombospondin motif 4 prevents cardiac fibrosis and dysfunction
Cardiovasc Res, 119 (10), 1915-1927
PubMed 37216909 DOI 10.1093/cvr/cvad078
Blom KB, Birkeland GK, Midtvedt K, Jenssen TG, Reisæter AV, Rollag H, Hartmann A, Sagedal S, Sjaastad I, Tylden G, Njølstad G, Nilsen E, Christensen A, Åsberg A, Birkeland JA (2023)
Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic Management
Transplantation, 107 (8), 1846-1853
PubMed 37211633 DOI 10.1097/TP.0000000000004615
Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic Management
Transplantation, 107 (8), 1846-1853
PubMed 37211633 DOI 10.1097/TP.0000000000004615
Andreassen K, Rixon C, Hansen MH, Hauge-Iversen IM, Zhang L, Sadredini M, Erusappan PM, Sjaastad I, Christensen G, Haugaa KH, Edvardsen T, Lunde IG, Stokke MK (2023)
Beneficial effects of exercise initiated before development of hypertrophic cardiomyopathy in genotype-positive mice
Am J Physiol Heart Circ Physiol, 324 (6), H881-H892
PubMed 37115627 DOI 10.1152/ajpheart.00701.2022
Beneficial effects of exercise initiated before development of hypertrophic cardiomyopathy in genotype-positive mice
Am J Physiol Heart Circ Physiol, 324 (6), H881-H892
PubMed 37115627 DOI 10.1152/ajpheart.00701.2022